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Bone marrow biopsy is useful for diagnosis of hematopoietic diseases. We have recently reported that
bone marrow biopsy from the ﬂipper might be useful for diagnosis of hematopoietic diseases in
dolphins. In this study, to demonstrate whether biopsy from the ﬂipper is useful for clinical diagnosis,
we investigated the gene expression proﬁles and proliferation and differentiation of bone marrow
mononuclear cell (BMMC) isolated from the humeral bone marrow of bottlenose dolphins. BMMC
exhibited gene expression proﬁles considered to be characteristic of hematopoietic cells. Similarly,
a colony forming unit assay showed that dolphin BMMC possessed vigorous colony forming ability. The
proliferation of hematopoietic progenitor cells resulted in the formation of three types of colonies,
containing neutrophils, monocytes/macrophages and eosinophils with or without megakaryocytes, all
of which could be identiﬁed based on the morphological characteristics and gene expression proﬁles
typically associated with hematopoietic markers. Thus, dolphin BMMCs from humeral bone marrow
contain many hematopoietic progenitor cells, and bone marrow biopsy from the ﬂipper is suggested
useful for clinical diagnosis for the dolphins.
& 2011 Elsevier Ltd CC BY-NC-ND license.. Open access under 1. Introduction
Bone marrow evaluation can be useful to conﬁrm diseases in
mammals in which the peripheral blood contains abnormal cells
or cell populations. For example, leucopenia, thrombocytopenia,
non-regenerative anemia, agranulocytosis, pancytopenia and leu-
kemias are often caused by pathogenic changes within the bone
marrow. In dolphins, bone marrow biopsy from vertebral body
has been introduced [1], and the procedure requires considerable
technical skills. Thus, to evaluate hematopoietic disease and blood
disorder of dolphins, alternative site for bone marrow biopsy,
which is easier to approach than vertebral body, should be
investigated.ar cell; CFU assay, colony
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G-CSFR, granulocyte
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).
Y-NC-ND license. The evolutionary history of dolphins and other cetaceans is
unique in that their terrestrial ancestors recolonized aquatic
environments, changing their morphology and physiology con-
siderably in the process [2]. The humerus of dolphins has a
cancellous structure and lacks an obvious marrow cavity [3,4].
We have recently reported that bone marrow biopsy from the
ﬂipper of a dolphin might be useful for clinical diagnostic work in
dolphins because bone marrow cells isolated from humeral bone
tissue were morphologically similar to the hematopoietic cells of
other vertebrates [4]. However, whether these bone marrow cells
function as hematopoietic cells, or whether they generate new
blood cells through cellular differentiation and proliferation, has
not yet been ascertained. In this study, we demonstrate that this
study shows that bottlenose dolphin BMMCs contain hematopoi-
etic progenitor cells within humeral bone marrow with the
capacity to yield hematopoietic cells in the presence of PHA-
LCM, and bone marrow biopsy from the ﬂipper is suggested useful
to diagnose hematopoietic disease for the dolphins.2. Materials and methods
2.1. Animal samples
A special note is required regarding any applications for the
animals used in this study. Humeral bone samples of bottlenose
T. Segawa et al. / Results in Immunology 1 (2011) 1–52dolphins (Tursiops truncatus) were obtained from Taiji Fisheries
Cooperative Union, Wakayama, Japan, with the permission of the
Wakayama Prefectural Government and under the supervision
of the Fisheries Agency of Japan. With the cooperation of the
National Research Institute of Far Seas Fisheries, we collected
pectoral ﬂippers and data from these catches at a ﬁshing port in
January 2010. Peripheral blood samples from bottlenose dolphins
were provided by the Shinagawa Aquarium, Tokyo, Japan.2.2. Cells
BMMCs were isolated from the humeral bone marrow of
bottlenose dolphins. Brieﬂy, a small piece of cancellous bone
was obtained using a cork borer and the marrow cells were
ﬂushed out with phosphate buffered saline (PBS; pH 7.4) using an
18G needle and a 10 ml syringe in petridish. Five milliliters of the
bone marrow cell suspension was layered onto 5 ml of Lympho-
prep (Axis-Shield PoC AS, Norway) and centrifuged at 760g for
30 min. The mononuclear, cell-enriched fraction containing
BMMC was washed twice with PBS and resuspended in Iscove’s
Modiﬁed Dulbecco’s Medium (IMDM; Gibco-BRL, NY) at a ﬁnal
concentration of 1.0107 cells/ml. Isolation of BMMC was per-
formed within 10 h after death of the animals. Peripheral blood
samples were drawn from the ventral tail ﬂuke into heparinized
vacutainer tubes. Polymorphonuclear leukocyte (PMN) andTable 1
Primers used for expression analysis in this study.
Gene Primers sequence (50-30) PCR produ
CD34 F ATAGTACCAGCCCTGTGACATC 491
R GCGGGTTCATCAGGAAATAGC
GATA2 F ACGGCTACCCCTCTCTGG 181
R GCCATAAGGTGGTGGTTGT
SCL/tal-1 F AAGCTCAGCAAGAATGAGATCC 204
R GGAGTTCGGGGACAGCAC
NE F CGCACTGTCTGAACGGCAT 331
R GCTGTCACCACGGTCACG
G-CSFR F ACCTTCCAACTGCCTTCAGA 276
R CCCTGCAATGCTTCCATTAT
MPO F GGGACAGCCGCTCAAGTG 259
R GGGTCCACCGAGTCATTGTA
Epx F CCGTCAACACCTTCTTCCAT 261
R CCACGATCTTCCGAGCCT
CD11b F CGGATAGAAAGGGGGTCATT 266
R ACCATCGGAGGTGAAGACAG
M-CSFR F AATACATCCGCAGGGACAGC 349
R ATCCACTTCACGGGCAGG
CD14 F AACTTGTGCGGACAGAGAGC 426
R GAAGCAGTACGCTGACACGA
MSR F CATGAGCAACGTGGAGAAGA 221
R GCAAATCAAGCAGTGTGGTG
b-Globin F CTGTCCACTGCTGATGCTGT 229
R GGGTGAATTCCTTGCCAAA
EPOR F CCCACAAGGGTAACTTCCAG 290
R TGCTATGTCCAAATCGCCAC
GATA1 F GGCAGTTTCCTGGAGACCTT 243
R CGTTGCTCCGCAGTTCAG
CD41 F ACCCACATCCAGGAACAGAC 276
R CTCATTCTCCCTCTTCTGGTTAC
GATA3 F AAGGCAGGGAGTGTGTGAAC 327
R TTTTTCGGTTTCTGGTCTGG
TCRb F TGGTATCGTCAGTTCCCG 176
R AAGTAGAGGCTGCTGTCGG
Pax5 F CAAACCAAAGGTTGCCACAC 388
R CGTCAGTGAGTGACCGTTCG
EBF F CCTGGTGTTGTAGAGGTCACAT 418
R TGAAACCCTGATTGGTAGCC
PU.1 F GGATGTGCCTCCCGTACC 271
R TTGTGCTTGGACGAGAACTG
b-Actin F CAGGCTGTGCTGTCCTTGTA 392
R AGGAAGGAAGGCTGGAAGAGperipheral blood mononuclear cell (PBMC) were isolated as
described previously [5,6]. Brieﬂy, dolphin peripheral blood was
overlaid on Lymphoprep (Axis-Shield PoC AS) in a polypropylene
tube and centrifuged at 760g for 30 min. The PMN (lower phase)
and the PBMC (upper phase) were then isolated and resuspended
in IMDM at a ﬁnal concentration of 1.0107 cells/ml.
2.3. Preparation of conditioned medium for colony formation
To prepare mitogen-stimulated dolphin lymphocyte conditioned
medium (LCM), PBMCs at 1.0106 cells/ml were incubated in IMDM
containing 20% (v/v) fetal bovine serum (FBS), 4 mM GlutaMAX
(Invitrogen, CA), 100 U/ml penicillin, 100 mg/ml streptomycin and 1%
(w/v) phytohemagglutinin (PHA) (Sigma-Aldrich Japan, Japan). After
5–7 days incubation at 37 1C in a humidiﬁed atmosphere with 5%
CO2, the cultured cells were centrifuged and the supernatant was
passed through 0.22-mm ﬁlter and 3ml aliquots of the supernatant
were stored at 20 1C until use.
2.4. Colony forming unit (CFU) assay
To assess the proliferation and differentiation activity of
dolphin BMMC, a CFU assay was performed as previously
described [7]. Brieﬂy, BMMCs (1.0105 cells/ml) were suspended
in a mixture of IMDM containing 5105 M 2-mercaptoethanol,ct (bp) Target blood cells Accession no.
Hematopoietic stem/progenitor AB561091
Hematopoietic stem/progenitor AB603947
Hematopoietic progenitor AB603955
Developing granulocyte AB603952
Netrophil AB603949
Netrophil AB603951
Eosinophil AB603942
Monocyte/macrophage, neutrophil AB603939
Monocyte/macrophage AB603950
Monocyte/macrophage AB603941
Mature macrophage AB603943
Erythrocyte AB603938
Megakaryocyte-erythroid progenitor AB603945
Erythroid, megakaryocyte AB603946
Megakaryocyte AB603940
T-lymphoid cell AB603948
T-lymphoid cell DV799587
Early B-cell AB603953
Early B-cell AB603944
Myeloid, lymphoid AB603954
Housekeeping gene AB603937
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tion of 1.1%. One milliliter aliquots of this mixture were placed
into 35 mm petridishes (Falcon, USA) and incubated for 14 days at
37 1C in a humidiﬁed atmosphere with 5% CO2. After culture, the
morphology of the colonies was examined using an inverted
microscope. A cluster containing more than 40 cells was con-
sidered to be a colony. Individual colonies were plucked with a
10-ml micropipette tip under the inverted microscope; the colony
cells were then washed twice with PBS and stained with May-
Grunwald Giemsa.
2.5. Gene expression analysis
To characterize the BMMC and access the composition of colony
cells obtained by the CFU assay, the expression proﬁles of
hematopoietic marker genes involved in mouse and/or human
hematopoiesis were analyzed by RT-PCR (Table 1). The dolphin
homologs of these markers were newly identiﬁed by speciﬁc
primer-based RT-PCR and directly sequenced using an ABI
PRISM3130 Genetic Analyzer (Applied Biosystems, CA). The target
blood cells of the hematopoietic marker genes are as follows:
hematopoietic stem/progenitor cell markers—CD34, GATA2 and
SCL/tal-1 [8,9]; neutrophil markers—NE, G-CSFR and MPO [10,11];
eosinophil marker—Epx [12]; monocyte/macrophage and neutro-
phil marker—CD11b [10]; monocyte/macrophage markers—
M-CSFR, CD14 and MSR [10]; erythrocyte markers—b-globin and
EPOR [9,13,14]; erythrocyte and megakaryocyte marker—
GATA1 [9]; megakaryocyte marker—CD41 [15]; T-lymphoid cell
markers—GATA3 and TCRb [9,16]; B-cell markers—Pax5 and EBF
[14,17]; myeloid and lymphoid marker—PU.1 [10]. Total RNA was
extracted using ISOGEN (Nippon Gene, Japan) according to the
manufacturer’s instructions, and treated with DNase using a Turbo
DNA-free Kit (Ambion, TX) as prescribed by manufacturer. The
quantity and the purity (A260/A28041.6) of the total RNA were
assessed using a spectrophotometer (NanoDrop ND-1000S, Nano-
Drop Technologies, DE). Total RNA was reverse-transcribed using H
Minus M-MuLV Reverse Transcriptase (MBI Fermentas, Lithuania)
primed with an oligo-dT17 primer and PCR was performed using
Blend Taqs-Plus-DNA polymerase (TOYOBO, Japan) according to
the manufacturer’s instructions. The sequences of the primers used
in this study are shown in Table 1. The PCR conditions consisted of
an initial denaturation step of 94 1C for 2 min, followed by 30–45
cycles of 94 1C for 30 s, 60 1C for 30 s and a ﬁnal elongation step of
72 1C for 30 s.Fig. 1. Comparison of hematopoietic marker gene expression proﬁles between BMMC a
using hematopoietic marker genes that were not expressed in mature blood cells. BM
PBMC: peripheral blood mononuclear cells. b-actin was used as a control for the amou3. Results
3.1. Gene expression proﬁles of dolphin BMMC
To characterize the dolphin BMMC, the expression proﬁles of
the hematopoietic marker genes expressed in human and/or
mouse hematopoietic cells were compared with the expression
proﬁles of PMN and PBMC by RT-PCR (Fig. 1). Hematopoietic
marker genes, such as CD34, GATA2, SCL/tal-1, NE, EPOR, GATA1
and Pax5, were strongly expressed in BMMC, but not in PMN.
Slight expression of CD34, GATA2, GATA1 and Pax5 was observed
in PBMC.
3.2. CFU assay in dolphin BMMC
After 14 days of culture in petridishes, at least three types of
BMMC colonies could be identiﬁed based on morphology (Fig. 2A–C).
These colonies were referred to as ‘‘Type 1’’, ‘‘Type 2’’ and ‘‘Type 3’’
colonies. The total colony counts per petridish were 30–40 colonies,
of which each of the colonies accounted for approximately 5–20%,
30–35% and 40–60%. On the other hand, culture of the peripheral
blood leukocytes under the same conditions revealed that no PMN
cultures were produced and that only 0–2 colonies of Type 3 colony
cells were generated from PBMC. Type 1 colonies were composed of
numerous neutrophil-like cells and monocyte/macrophage-like cells,
as well as a few megakaryocyte-like cells and eosinophil-like cells
(Fig. 2D). Type 2 and 3 colonies primarily contained neutrophil-like
cells with a few monocyte/macrophage-like cells and eosinophil-like
cells (Fig. 2E and F).
3.3. Characterization of cells from colonies by gene expression
proﬁles
Hematopoietic marker gene expression proﬁles for the cells in
each of the colony types are shown in Fig. 3. For three types of
colonies, the hematopoietic marker gene expression proﬁles were
compared with the morphological characters observed in the CFU
assay; neutrophil markers (NE, G-CSFR and MPO), eosinophil marker
(Epx), monocyte/macrophage and neutrophil marker (CD11b),
monocyte/macrophage markers (M-CSFR, CD14 and MSR) were
identiﬁed, but the erythrocyte markers (b-globin and EPOR) and
B-cell markers (Pax5 and EBF) were not observed. The erythrocyte
and megakaryocyte marker (GATA1) and megakaryocyte marker
(CD41) were detected in Type 1 and Type 2 colonies, respectively,nd peripheral blood cells (PMN and PBMC) by RT-PCR. The RT-PCR was performed
MC: bone marrow mononuclear cells, PMN: polymorphonuclear leukocytes and
nt and the quality of cDNA.
Type 1 colony Type 2 colony Type 3 colony
MK
N
E
M
N
E
N
M
E
M
Fig. 2. Morphology and composition of the three types of colonies formed by dolphin BMMC. Panels A–C show Type 1, 2 and 3 colonies. Scale bars represent 200 mm.
Panels D–F show the cellular morphology of cells from each colony (D: Type 1, E: Type 2, F: Type 3). Scale bars indicate 40 mm. MK: megakaryocyte-like cell, N: neutrophil-
like cell, E: eosinophil-like cell, M: monocyte/macrophage-like cell. Cells in each colony were May-Grunwald Giemsa stained.
Fig. 3. Hematopoietic marker gene expression proﬁles for Type 1, 2 and 3 colony cells. BMMC: bone marrow mononuclear cells. Lane BMMC showed gene expression
before culture. b-actin was used as a control for the amount and the quality of cDNA.
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colonies and hematopoietic stem/progenitor cell markers (CD34 and
GATA2) were detected in Type 2 colonies.4. Discussion
Dolphin BMMCs are considered to be hematopoietic cell
populations, since the expression proﬁles of the hematopoietic
marker genes of dolphin BMMCs were similar to those of humans,
mice and ﬁsh [13,14,18,19], and because the expression proﬁles of
BMMC were stronger than those of PMN and PBMC. In PBMC, the
expression proﬁles of CD34, GATA2, GATA1 and Pax5 were weak,
and PBMC may contain only a few hematopoietic cells.
In the CFU assay, BMMC formed numerous colonies and at
least three types of hematopoietic progenitor cells differentiated
into a variety of mature and immature blood cells. The number of
BMMC colonies was higher than that observed in PMN and PBMC
colonies, and the CFU assay results support the assumption of a
hematopoietic function in the BMMC based on the marker
gene expression proﬁles of dolphin BMMC, PMN and PBMC. It
is therefore suggested that the dolphin BMMCs have more
hematopoietic cells than the other cell types, and that PBMCs
contain only a few hematopoietic cells. In this study, BMMCs were
lymphocyte-like cells isolated using Lymphoprep, and PHA-LCM
was used for the proliferation and the differentiation of bottle-
nose dolphin hematopoietic cells.
Based on morphological characteristics and hematopoietic marker
gene expression proﬁles, the three types of colonies formed by the
proliferation of hematopoietic progenitor cells consisted of the
following: Type 1 colonies contained at least neutrophils, mono-
cytes/macrophages, megakaryocytes and eosinophils. Type 2 colonies
contained at least neutrophils, monocytes/macrophages and eosino-
phils. Type 3 colonies contained neutrophils, monocytes/macrophages
and eosinophils. In all three types of colonies, marker gene expression
revealed that dolphin BMMC differentiated into mature blood cells.
CD34, GATA2 and GATA1, which are all expressed in immature blood
cells [8,9], either disappeared or weakly expressed in PMN or PBMC,
while mature blood cell markers such as MPO, Epx and MSR [10]
were expressed more strongly in dolphin PMN and PBMC (data not
shown). More speciﬁcally, Type 1 colonies were composed of at least
neutrophils, monocytes/macrophages, megakaryocytes, eosinophils
and possibly T-lymphoid cells, because T-lymphoid markers (GATA3
and TCRb) were detected in this colony type. Type 2 colonies were
composed of neutrophils, monocytes/macrophages and eosinophils,
and although megakaryocyte-like cells were not observed, both
megakaryocyte markers (CD41 and GATA1) and hematopoietic
stem/progenitor cell markers (CD34 and GATA2) were detected.
Since megakaryocyte progenitor cells express GATA2 and CD34 in
mice and humans, respectively [20,21], it is possible that Type
2 colonies contained megakaryocyte progenitor cells as these are
difﬁcult to identify using morphological characters. Type 3 colonies
were composed of neutrophils, monocytes/macrophages and eosi-
nophils. Thus, dolphin BMMC had numerous types of hematopoietic
progenitor cells from which new blood cells were produced by
proliferation and differentiation, implying that dolphin BMMCs were
hematopoietic cell populations and the humeral bone marrow is a
hematopoietic organ in dolphins.
In conclusion, humeral bonemarrow is a source of hematopoietic
progenitor cells, and bone marrow biopsy from the ﬂipper of the
dolphin is useful. We demonstrated that dolphin BMMCs contain
hematopoietic progenitor cells that differentiate into a variety of
mature and immature blood cell populations in humeral bone
marrow, which functions as a hematopoietic organ. However, since
we were unable to determine whether dolphin BMMC contained
erythroid or lymphocyte hematopoietic progenitor cells, futureresearch using improved culture systems should be undertaken to
clarify this point. In addition, studies of extramedullary hemopoiesis
such as spleen or other organs were not examined. This study
should be undertaken to clarify the components and functioning of
the hematopoietic system as doing so may improve the diagnosis of
hematopoietic disease in dolphins.Acknowledgments
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